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EXPLANATORY MEMORANDUM 
The Commission presented to Council on 28 May 1990 the "Proposal for a Council 
Decision adopting a specific research and technological development programme in the 
field of Biotechnology (1990-1994)". 
The European Parliament having given its opinion at first reading on 9 October 1991, the 
Commission presented an amended proposal which incorporated the 31 amendments 
which it had retained. This proposal was transmitted to Council on 18 October 1991. 
On the basis of this amended proposal, the Council adopted on 28 November 1991 its 
Common Position, which incorporates, sometimes with modifications, 30 of the 31 
amendments taken up by the Commission, as well as all the elements deriving from the 
. inter-.institutional agreement of 17 April 1991. The Commission was able to agree to this 
Common Position. In the course of the plenary session of February 1992, the Parliament 
adopted 4 amendments to the Common Position, bearing on the statement of scientific 
and technical objectives in Annex I. 
Amendments nos. 1 and 4 have been accepted by the Commission, the latter subject to 
reformulation. Amendment no. 1 introduces drafting modifications 1 which emphasise 
the fundamental importance of a better understanding of biological and genetic 
mechanisms. Amendment no. 4 specifies the themes on which the assessments of social, 
legal and ethical aspects of biotechnology should focus. 
Without prejudice to the orientation of the Common Position, these amendments refine 
certain objectives which the Parliament wished particularly to highlight. 
To take account of the position of the European Parliament, the Commission presents 
to Council, on the basis of Article 149, paragraph 2 sub-section d of the EEC Treaty, -a 
re-examined proposal which is based on the text of the Common Position with the 
exception of two modifications. 
1 Does not apply to the Greek and French versions. 
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Re-examined proposal for a 
COUNCIL DECISION 
adopting a specific research and technological 
development programme in the field of 
Biotechnology 
(1990-1994) 
THE COUNCIL OF THE EUROPEAN COMMUNITIES, 
Having regard to the Treaty establishing the European Economic community, and in 
particular Article 130q(2) thereof, 
Having regard to the proposal from the Commission 1, 
In co-operation with the European Parliament 2, 
Having regard to the opinion of the Economic and Social Committee 3, 
1 OJ N° C 174, 16.7.1990, p. 53. 
2 Opinion delivered on (not yet published in the Official Journal) and Decision of 
(not yet published in the Official Journal). 
3 OJ N° C 31, 6.2.1991, p. 14. 
2 
Whereas, by its Decision 90/221/Euratom, EEC 1 the Council adopted a third framework 
programme for community activities in the field of research and technological 
development (1990-1994), specifying, inter alia, the activities to be pursued for 
contributing to the development of Europe's potential for understanding and using the 
properties and structures of living matter; whereas this Decision should be taken in the 
light of the grounds set out in the preamble to Decision 90/221/Euratom/EEC; 
Whereas Article 130k of the Treaty stipulates that the framework programme is to be 
implemented through specific programmes developed within each activity; 
Whereas research and technological development in this field should be linked to various 
relevant community policies and objectives; 
Whereas, pursuant to Article 4 and Annex I of Decision 90/221/Euratom, EEC, the 
amount deemed necessary for the whole framework programme includes an amount of 
Ecu 57 million for the centralized action of dissemination and exploitation of results, to 
be divided up in proportion to the amount envisaged for each of the actions; 
Whereas, in the context of this programme, an assessment should be made of the 
economic and social impact as well as of any technological risks; 
Whereas basic research in the field of biotechnology must be encouraged throughout the 
community; 
1 OJ N° L 117, 8.5.1990, p. 28. 
3 
Whereas, in addition to the specific programme concerning human resources and 
mobility, it is necessary to encourage the training of research workers in the context of 
this programme; 
Whereas biological research, in particular that which uses the methods of recombinant 
DNA, is often subject to national laws with which the contractors must comply; 
Whereas on 23 April 1990 the Council adopted Directive 90/219/EEC on the contained 
use of genetically modified micro-organisms 1 and Directive 90/220/EEC on the 
deliberate release into the environment of genetically modified organisms 2; 
Whereas the positive development of biotechnology could be enhanced by concerted 
actions; 
Whereas actions should be undertaken to ensure that the necessary consideration is given 
to the ethical and social effects of these projects, and their applications in agriculture, 
industry, health care and the environment; whereas such actions will ensure that 
information is made available to the public concerning the content of the programme; 
Whereas the results which may be achieved by genetic research make it necessary to 
adopt an integrated approach which takes account of the scientific, safety, ethical and 
legal aspects of possible applications and of the need to ensure that the results are not 
used in an improper manner or subject to misrepresentation; 
1 OJ N° L 117, 8.5.1990, p. 1. 
2 OJ N° L 117, 8.5.1990, p. 15. 
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" 
Whereas the Commission has announced its intention to examine further the ethical 
implication~ of biotechnology using the appropriate advisory structure; 
Whereas Decision 90/221/Euratom, EEC provides that a particular aim of Community 
research must be to strengthen the scientific and technological basis of European industry 
and to encourage it to become more competitive at international level; whereas it also 
provides that Community action is justified where research contributes, inter alia, to the 
strengthening of the economic and social cohesion of the Community and to the 
promotion of its overall harmonious development, while being consistent with the pursuit 
of scientific and technical excellence ; whereas the programme in the field of 
biotechnology is looked upon as contributing to the achievement of these objectives; 
Whereas small and medium-sized enterprises (SME) should be involved to the maximum 
extent possible in this programme ; whereas account should be taken of their special 
requirements, without prejudice to the scientific and technical quality of the programme; 
Whereas research in biotechnology may lead to improvements in agriculture and 
industrial efficiency and viability, in the preservation of the environment and health, and 
in quality products for the consumer; 
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Whereas, in accordance with Article 130g of the Treaty, the Community's activities aimed 
at strengthening the scientific and technological basis of European industry and 
encouraging it to become more competitive include promoting co-operation on. research 
and technological development with third countries and international organizatirnrn$; 
whereas such co-operation may prove particularly beneficial for the development of thfa 
programme; 
Whereas it is necessary, as Annex II to Decision 90/221/Euratom~ EEC prnvide§, to 
reinforce biological knowledge as the common and integrated foundatioml liletedled for 
applications in agriculture, industry, nutrition and the environment; 
Whereas the Scientific and Technical Research Committee (CREST) has been cons1.dted9 
HAS ADOPTED THIS DECISION: 
Article 1 
A specific research and technological development programme in the field of 
biotechnology, as defined in Annex I, is hereby adopted for a period commencing on ... 1 
and ending on 31 December 1994. 
1 Date of adoption by Council. 
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Article 2 
1. The funds estimated as necessary for the execution of the programme referred to in 
Article 1 amount to Ecu 162,36 million, including expenditure on staff and administration 
amounting to Ecu 7 million. 
2. An indicative allocation of funds is set out in Annex II. 
3. Should the Council take a decision pursuant to Article 1( 4) of Decision 
90/221/Euratom, EEC, this Decision shall be adapted accordingly. 
Article 3 
Detailed rules for the implementation of the programme and the amount of the 
community's financial contribution are set out in Annex III. 
Article 4 
1. In the second year of the implementation of the programme, the Commission shall 
review it and send a report on the results of its review to the European Parliament, the 
Council and the Economic and Social Committee; the report shall be accompanied, 
where necessary, by proposals for amendment of the programme. 
2. At the end of the programme, an evaluation of the results achieved shall be conducted 
for the Commission by a group of independent experts. The group's report, together with 
the Commission's comments, shall be submitted to the European Parliament, the Council 
and the Economic and Social Committee. 
3. The reports referred to in paragraphs 1 and 2 shall be established having regard to the 
objectives set out in Annex I to this Decision and in accordance with Article 2{ 4) of 
Decision 90/221/Euratom, EEC. 
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Article 5 
1. The Commission ,shall be responsible for the implementation of the programme. 
2. Contracts concluded by the Commission shall govern the rights and obligations of each 
party, in particular the arrangements for the dissemination, protection and exploitation 
of research results, in accordance with the provisions adopted pursuant to the second 
subparagraph of Article 130 k of the Treaty. 
3 .. A workprogramme shall be drawn up in accordance with the aims set out in·Annex I -
and updated where necessary. It shall set out the detailed objectives and types of projects 
to be undertaken, and the financial arrangements to be made for them. The Commission 
shall make calls for proposals for projects on the basis of the work programme. 
Article 6 
The Commission shall be assisted by a Committee composed of representatives of the 
Member States and chaired by the representative of the Commission. 
The representative of the Commission shall submit to the Committee a draft of the 
measures to be taken. The Committee shall deliver its opinion within a time limit which 
the Chairman may lay down according to the urgency of the matter. The opinion shall 
be delivered by the majority provided for in Art~cle 148(2) of the Treaty as regards 
adoption of decisions which the Council is required to adopt on a proposal from the 
Commission. The votes of the representatives of the Member States within the 
Committee shall be weighted in the manner set out in that Article. The chairman shall 
not vote. 
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The Commission shall adopt the measures envisaged when they are in accordance with 
the opinion of the Committee. 
When the measures envisaged are not in accordance with the Committee's opinion, or 
if no opinion is delivered, the Commission shall without delay submit to the Council a 
proposal relating to the measures to be taken. The Council shall act by a qualified 
majority. 
If, on the expiry of a period of three months from referral of the matter to the Council, 
the latter has not acted, the proposed measures shall be adopted by the Commission. 
Article 7 
1. The procedure laid down in Article 6 shall apply to: 
the preparation and updating of the work programme referred to in Article 5(3); 
the contents of the calls for proposals; 
the assessment of the projects and concerted actions provided for in Annex III 
and the estimated amount of the Community's contribution to them where this 
amount exceeds Beu 0,3 million; 
departures from the general rules set out in Annex III; 
the participation in i,my project by non-Community organizations and enterprises 
referred to in Article 8; 
9 
any adaptation of the indicative breakdown of the amount set out in Annex II; 
- the measures to be undertaken to evaluate the: programme; 
· arrangements for the dissemination, protection,and exploitatiqn uf t}le .results of.-
. research carried -out under the ·programme. 
·2. 'Where, pursuant lO the third indent of paragraph 1, the al1101lnt of the. Compiunity 
-contribution is less than, -or ,equal to, Beu ,Q,3 million, the -~mmission sh~ll .inform the 
'Cotnmittee of the projects and cqncerted actions and of the:outcome of t~eir assessment. 
The Commission shall· also inform the ,Committee of the cimpleme·ntation of the 
accompanying measures referred to in .Annex Ul. 
Article 8 
1. The Commission is hereby authorized to negotiate, in accordance with Article 130n of 
the Treaty, international agreements with third countries which are members of COST, 
in particular the member countries of EFT A and t~e countries of central and Eastern 
Europe, with a view to associating them with all, or part, ·Of the programme. 
2. When framework agreements for scientific and technical co-operation have been 
concluded between the Community and European non-Member States, bodies and 
enterprises established in those countries may, in accordance with the procedures laid 
down in Article 6 and on the basis of the criterion of mutual benefit, be allowed to 
become partners in a project undertaken within the programme. For projects in Area 3 
of Annex I, this option may be extended to bodies and enterprises established in other 
third countries as well as to international organisations engaged in research in this area. 
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No contrncting body based! m.JJ1tside the Commll.llnity arndl parrtidpatiirng 2\$ a praurtimeir h& a 
project lUl)fiHdleirt21lken ll.mdler the pmgrnmme may beirueflit from Commuli1lnty fnlTila1.irndrrug foir thfa 
pmgrramme. SlUlch bodie§ shall teol11ltrilbm1te to the gernernU rmdlmil11lfatratnve to!it~1o 
Artide 9 
This Decision is addressed to the Member States. 
Done at Brussels, 
For the Counci19 
The president 
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ANNEX I 
SCIBNTIFIC AND TBCHNICAL '.0BJECTIVFS-AND::-,£0NTENT 
This specific programme fully reflects the approach embodied· in the Third Framework 
Programme in terms of the scientific· and technical goals and the underlying aims which 
it pursues. 
Paragraph 4A of Annex II of the Framework Programme· forms an integral part of the 
presentspecific programme. In particular, the objectives of the:BRIDGE programme will 
be extended. 
Pre-normative research will be carried out in each of the areas descnbed · below, with 
emphasis on .the safety .assessment of-new .techniques. and novel. products. 
The ethical and social implications of biotechnology will . be monitored and studied. A 
multidisciplinary approach involving representatives from the various sciences, professions 
and activities concerned will be pursued. For all projects conducted in this framework, 
contractors will be requested to provide, when applicable, information necessary for the 
detailed evaluation of the social, ethical and ecological impact of their studies, and, where 
necessary, approval from the responsible · authorities. The provisions of relevant 
Community directives must be applied as regards the ecological impact. These· must also 
be applied to work carried out as a consequence of the provisions laid down in Article 
8 of the Decision. 
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In monitoring, studying, and evaluating tpe ethical, social and economic implications and 
impacts of biotechnology, attention will be given to : 
diverse expert or public perceptions of its benefits and hazards, including the 
effects on such perceptions of diverse cultural and institutional perspectives; 
the factors which influence the credibility and acceptability of scientific evidence 
in policy areas concerned with biotechnology, including such areas as animal 
welfare, environmental protection, and consumer safety; 
the implications of biotechnology, in the light of ethical guidelines prepared by 
national or international bodies; 
the potential consequences for social progress and economic development of the 
applications and innovations in agriculture, medicine and industry which may 
result from biotechnology R&D; and the influence upon such progress and 
development of public policies for the promotion and regulation of biotechnology. 
Information technology will be used throughout the programme for collecting, pooling, 
analyzing, distributing or simulating data. 
Research will be carried out at the level of molecules, cells, organisms and populations. 
Integration between levels will be assured. 
The following presents an analytical description of the content of the programme, based 
on, and taking account of, the above elements. 
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Area 1 Molecular approaches 
Protein structure and function 
Research under this theme is aimed at two goals. First, to understand and control 
biological functions carried out by proteins ( enzymes, hormones, antibodies, receptors, 
body structures, etc.). Second, to produce tailor-made proteins adapted to the specific 
requirements of man ( for example, new drugs, industrial enzymes). 
Target areas will include enzymes and proteins associated with biological membranes. 
A specific objective of the programme will be the analysis of structure-function 
relationships for a number of membrane proteins. 
Structure of genes 
The goal is a greater understanding of biological and genetic mechanisms. The study of 
the genetic message in representative species will be pursued at two levels: precise 
ordering of the genes within chromosomes (gene mapping) and detailed determination 
of the chemical composition of genes (gene sequencing). 
Efforts will be undertaken to contribute to the sequencing work of the entire genome of 
yeast, which displays a genetic structure and organisation (genome) comparable to that 
of p]ants and animals, and to initiate a Community effort for sequencing genes in suitable 
microorganism, plant and animal species. 
A specific objective will be the sequencing of more than 10 million nucleotides in the 
organisms studied. 
Close liaison will be maintained wnth research under the Human Genome Analysis 
programme to ensure that developments in methodology, mapping and sequencing 
techniques are shared with mutual benefito 
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Expression of genes 
In order to make full use of the above information on gene structure, the processes 
through which the information stored as DNA in the genes is expressed in the form of 
active proteins will be studied in some models of practical importance - transcription 
factors, factors affecting transcription, RNA polymerases, their interactions with signals, 
ligands, DNA and posttranscriptional processes. A specific objective is the analysis of a 
number of DNA polymerases and transcription factors in yeast, plants and mammalian 
cells. 
Area 2 Cellular and organism approaches 
Cellular regeneration, reproduction and development of living organisms 
In order to provide basic knowledge required by biotechnology, comparative studies of 
reproductive events (meiotic pairing, gamete packaging, gamete recognition and 
fertilization), cell-cell interaction and cell replication 1n animals and plants will be 
undertaken. Research will be centred on the control of development, cell commitment 
and cell totipotency in higher organisms starting with the simplest levels of organisation, 
namely gametes, eggs, proliferating lines and their reorganisation into organs and 
embryos. Research projects on human embryos are not included in this programme. 
At the same time, with regard to pre-normative research, in vitro test systems will be 
elaborated which take into account the high specificity of modern drugs and their 
potential toxic effects during cell differentiation and organogenesis. 
Metabolism of animals, plants and microbes: essential physiological traits. 
The objective is to provide industrial and agricultural operators with the basic knowledge 
required for a more rational exploitation of resources in production, processing and 
animal husbandry. 
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The analysis of the biological material with a view to studying and protecting human 
health will utilize new animal models including, where necessary, transgenic animafat Any 
unnecessary suffering of such animals will be strictly avoided, and the Community 
provisions of Council Directive 86/609/EEC of 24 November 1986 1 on the protection of 
animals used for experimental and other scientific purposes shall be appliedo 
Research will concern the regulatory mechanisms governing some of the biological 
functions or metabolic activities in species which are important to man ( e.g., as specific 
objectives, production and secretion in micro-organisms, extremophile micro-organisms, 
metabolic pathways under extreme environments, nitrate assimilation in plants, food 
utilisation and metabolic control in animals, etc.). 
Communication systems within living matter 
The goal is to- provide industrial biotechnologists, agricultural and medical operators with 
a new approach to dealing with the complexity of living systems. This emerging subject 
will be studied at the cellular and systemic level. 
Research will be focused on the immune and the nervous systems. Immunological studie~ 
will concern the complex interaction between the three main types of cells ( antigen-
presenting ceUs, T-lymphocytes and B-lymphocytes) responsible for the reaction of the 
animal body to foreign substances (antigens). Pharmacological and toxicological test 
systems wm be developed for prenormative purposes for the evaluation of biotechnology 
products1 with special attention to immune reactions in "drug targetingn and 
immunotmdcology as sud110 Synergism with protein engineering will be assuredo 
In neurobiology, attention wiU be given to the basic unit of the brain, the neurons and 
theirinteractions. The biochemical, pharmacological and genetic characterisation of newly 
discovered neuroreceptors systems will constitute a specific objective of the programme. 
1 OJ N° L 358, 18.12.1986, p. 1. 
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Area 3. Ecology and population biology 
Ecological implications of biotechnology 
The goal is to study the environmental implications of biotechnology and, in particular, 
of the release by man of living organisms in the environment in connection with the 
industrial, agricultural and environmental policies of the Community" 
Particularly in the case of microorganisms, the systematic analysis of possible risks will 
be carried out taking into consideration the need for a comprehensive understanding of 
the relevant characteristics of the ecosystems involved, such as the soit Research will 
include the analysis of representative examples of interactions between microbial 
populations and other organisms in the ecosystems; the study of the impact of the 
introduction of genetically modified or genetically marked microorganisms on the 
rhizosphere or leaf surface; the determination of the behaviour and effects upon 
ecosystems of organisms including those modified by genetic engineering (including, as 
a complement to ongoing research in BRIDGE, fishes and insects). 
Conservation of genetic resources 
The aim is to ascertain the real dimension of the problem of loss of genetic diversity. 
Knowledge of genetic erosion in plants, ,animals and microorganisms will be pursued, 
collected and circulated. 
Taxonomy will be revitalised with inputs from molecular biology, providing specific and 
targetted support to decentralised collections of biotic materials; this support will be 
restricted to research and will exclude the maintenance · or expansion of 
existinwcollections; a systematic assessment of the residual genetic variability of microbial, 
plant and animal species and varieties which have played a major role in regional and 
traditional European agriculture and food will be carried outc 
Close co-ordination wm be maintained with other relevant research programmesj 
induding "Biomedicine and Health" and "Environment". 
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ANNEX II 
INDICATIVE ALLOCATION OF FUNDS DEEMED NECESSARY 
Ecu millions 
Area 1 - Molecular approaches . 64 
Area 2 - Cellular and organism approaches . 81 
Area 3 - Ecology and population biology. 
_ 17.36 
TOTAL 162.36 1 2 3 
·The breakdown between different areas .does not exclude the .possibilitrthat projects 
could cover several areas. 
1 Including expenditure on staff amounting to Ecu 3,5 million and administration 
expenditure totalling Ecu 3,5 million. 
·
2 An amount deemed necessary of Ecu 1,64 million, not included in ihe Ecu 162,36 
million, will be earmarked as the contribution from the specific programme in the 
field of biotechnology to the centralized scheme for the dissemination and 
exploitation of results. 
At least 10% of the funds will be allocated to basic research. Betv,een 5 and 7% 
of the funds will be allocated to training of researchers. Up to 3% of the funds 
wm be allocated to the assessment of ethical and socio-economic effects and 
technological risks. 
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ANNEX III 
RULES FOR IMPLEMENTING THE PROGRAMME 
1. The Commission will implement the programme on the basis of the scientific 
and technical content described in Annex I. 
2. The rules for implementing the programme, referred to in Article 3, comprise 
research and technological development projects, concerted actions and 
accompanying measures. Selection of projects must take account of. the criteria 
listed in Annex III to Decision 90/221/Euratom, EEC and of the objectives set 
out in Annex I to this programme. 
Research projects 
The projects will be the subject of shared-cost research and 
technological development contracts and Community financial 
participation which will not normally be more than 50%. Universities 
and other research centres participating in shared-cost projects will have 
the option of requesting, for each project, either 50% funding of total 
expenditure or 100% funding of the additional marginal costs. 
Shared-cost research projects must, as a general rule, be carried out by 
participants established within the Community. Projects in which, for 
example, universities, research organizations and industrial firms, 
including small and medium-sized enterprises, may take part must 
provide, as a general rule, for the participation of at least two partners, 
independent of each other and established in different Member States. 
Contracts relating to shared-cost research projects must, as a general 
rule, be concluded following a selection procedure based on calls for 
proposals published in the Official Journal of the European 
Communities. 
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Co-operative research projects 
Co-operative research is intended for a group of undertakings, in 
particular SMEs, which do not have their own research facilities, in 
order to resolve common technical problems. One or more outside 
organizations ( research associations, universities or undertakings) will be 
appointed to carry out the research. 
50% of the research costs of these projects will be covered for a period 
normally not exceeding two years. These projects must be submitted by 
undertakings which are to take part in planning and piloting the 
research and implementing the results. 
Concerted actions 
Concerted actions consist of action by the Community to co-ordinate the 
individual research activities carried· out in the Member States. They 
may benefit from funding of up to 100% of co-ordinating expenditure. 
Accompanying measures 
The accompanying measures referred to in Article 7 and described in 
Annex I will in particular be implemented through: 
the organization of seminars, workshops and scientific conferences; 
internal co-ordination through the creation of integrating groups; 
advanced technology training programmes, with the emphasis being 
placed on multidisciplinarity; 
promotion of the exploitation of results; 
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independent scientific and strategic evaluation of the operation of the 
projects and the programme. 
3. The knowledge acquired in the course of the projects will be disseminated both 
within the specific programme and by means of a centralized activity, pursuant 
to the Decision referred to in the third subparagraph of Article 4 of 
Decision 90/221/Euratom, EEC. 
4. Each proposal should include an environmental impact statement. The 
statement should also include an undertaking. to comply with the relevant safety . 
rules. 
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Rejected amendments 
Amendment n° 2 sought to modify the first sub=title of the area w'Ecology and population 
biology"o The wording proposed by the Parliament extends however beyond the J 
framework of this specific programme and the limits of biotechnology in order to include 
complete parts of ecology. 
Amendment n° 3 sought to open activities on genetic resource conservation to 
cooperation with non-participating organisations, possibly established outside the 
Community. Article 8 paragraph 2 of the Common Position meets however. to a sufficient 
extent the expectation of the European Parliament in specifying, for projects falling under 
the area "Ecology and Population Biology", that the possibility of cooperation is in 
principle open to bodies and enterprises in any third country as well as to international 
organisations active in this research area. 
l 
( 
(Amendment No. 2) 
Annex I, area 3, first subtitle 
Ecological implications of 
biotechnology 
Ecology and environmental impact 
assessment of biotechnology 
(Amendment No. 3) 
Annex I, area 3, fourth paragraph a (new) 
These activities will be carried out 
in cooperation with relevant 
international organizations active 
in this field within the European 
Community, national and regional 
aqricul tural research organizations 
and countries outside the European 
Community, with particular reference 
to Third World countries. 
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